Bio-Techne (TECH) EBT Margin Growth (3y) (2012 - 2026)

Bio-Techne (TECH) EBT Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9,237.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 441.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -408.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 363.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Bio-Techne 11.23 Bn 11.02 Bn 208.29 Mn -439.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -439.00
Dec 31, 2025 -730.00
Sep 30, 2025 -516,905.00
Jun 30, 2025 -6,203.00
Mar 31, 2025 -1,158.00
Dec 31, 2024 -1,757.00
Sep 30, 2024 -1,227.00
Jun 30, 2024 731.00
Mar 31, 2024 151.00
Dec 31, 2023 -1,289.00
Sep 30, 2023 -137.00
Jun 30, 2023 1,201.00
Mar 31, 2023 321.00
Dec 31, 2022 -5,683.00
Sep 30, 2022 517,608.00
Jun 30, 2022 4,897.00
Mar 31, 2022 -330.00
Dec 31, 2021 1,953.00
Sep 30, 2021 1,535.00
Jun 30, 2021 -2,847.00